Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sleep Number Corporation SEC filings document its personalized sleep-products business, capital structure and public-company governance. Form 8-K disclosures cover operating results, Regulation FD investor presentations, amendments to its credit agreement, covenant and liquidity terms, financing arrangements, officer appointments, board changes and compensatory arrangements.
The company’s proxy materials describe director matters, executive compensation, equity awards and shareholder voting items. Together, the filings provide formal records for Sleep Number’s direct-to-consumer retail model, product and marketing strategy, debt obligations, internal reporting roles and governance practices.
Sleep Number Corporation entered a Forbearance Agreement and Thirteenth Amendment to its Credit Agreement, adding a new $25 million term loan maturing on June 30, 2026 at one‑month term SOFR plus 8%, with a $5 million amortization due June 1, 2026.
The amendment provides covenant relief and forbearance from lenders regarding specified existing defaults, waives the $30 million minimum liquidity covenant until the first week ending after July 1, 2026, tightens reporting and cash controls, and requires milestones toward a strategic transaction to repay lenders in full. On April 27, 2026, the term loan was fully funded and revolving loans outstanding reached $447.2 million, contributing to roughly $55 million of additional liquidity highlighted by the company.
Management states that performance for the first quarter of 2026 is in line with prior expectations and continues to emphasize a turnaround plan centered on a major new product portfolio, an integrated marketing campaign and ongoing evaluation of strategic business and financing options, with first-quarter results expected on May 12, 2026.
Sleep Number Corporation entered a Forbearance Agreement and Thirteenth Amendment to its Credit Agreement, adding a new $25 million term loan maturing on June 30, 2026 at one‑month term SOFR plus 8%, with a $5 million amortization due June 1, 2026.
The amendment provides covenant relief and forbearance from lenders regarding specified existing defaults, waives the $30 million minimum liquidity covenant until the first week ending after July 1, 2026, tightens reporting and cash controls, and requires milestones toward a strategic transaction to repay lenders in full. On April 27, 2026, the term loan was fully funded and revolving loans outstanding reached $447.2 million, contributing to roughly $55 million of additional liquidity highlighted by the company.
Management states that performance for the first quarter of 2026 is in line with prior expectations and continues to emphasize a turnaround plan centered on a major new product portfolio, an integrated marketing campaign and ongoing evaluation of strategic business and financing options, with first-quarter results expected on May 12, 2026.
Sleep Number Corporation is asking shareholders to vote on seven proposals at its virtual Annual Meeting on May 21, 2026, including electing three directors and multiple governance changes. The Board seeks approval to declassify itself and to remove supermajority voting requirements for director matters and certain major transactions, shifting to simple majority standards. Shareholders are also asked to ratify Deloitte & Touche LLP as auditor, approve executive pay on an advisory basis, and add 750,000 shares to the 2020 Equity Incentive Plan.
The company describes a turnaround plan under CEO Linda Findley, citing $136 million of cost reductions versus 2024, an amended bank agreement through 2027, and its “Sleep Number Shifts” strategy focused on product simplification, sharper marketing, and broader distribution. For 2025, Sleep Number reports net sales of $1.4 billion, an operating loss of $46.6 million, adjusted EBITDA of $78.3 million, a diluted loss per share of $5.77, and a net leverage ratio of 4.1x EBITDAR versus a 4.5x covenant maximum. The Compensation Committee notes that 2025 annual incentives and 2023 performance share units paid out at zero, emphasizing pay-for-performance alignment.
Sleep Number Corp. Schedule 13G/A amendment: M Partners Fund LP, M Partners Fund (GP) LLC and Ali John Mirshekari report no beneficial ownership of Sleep Number common stock. The filing states 0 shares and 0% ownership, citing 22,864,000 shares outstanding as of January 31, 2026.
The report explains the ownership chain (M Partners Fund LP; general partner M Partners Fund (GP) LLC; managing member Ali John Mirshekari) and includes signed attestations dated 03/27/2026.
Sleep Number Corp disclosure: The Vanguard Group filed Amendment No. 14 to its Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of the class. The amendment notes an internal realignment effective January 12, 2026 that caused certain subsidiaries to report holdings separately.
The filing is signed by Ashley Grim, Head of Global Fund Administration, dated March 27, 2026.
Sleep Number Corporation is soliciting proxies for its 2026 Annual Meeting and requests shareholder votes on director elections and amendments to declassify the Board and eliminate certain supermajority vote provisions.
Management highlights a turnaround plan called Sleep Number Shifts, cost reductions of $136 million (excluding restructuring and other non-recurring costs versus 2024), and an amended bank agreement extended through 2027. The Proxy discloses 2025 results: net sales of $1.4 billion (down 16%), a net operating loss of $46.6 million, adjusted EBITDA of $78.3 million, diluted loss per share of $5.77, and a net leverage ratio of 4.1x EBITDAR with $58 million liquidity. Proposals 2–4 require an affirmative vote of two-thirds of shares outstanding; similar proposals received ~98% support from voting shareholders at the 2025 meeting but fell short of the required two-thirds of all shares outstanding.
Sleep Number Corporation reported that board member Hilary A. Schneider has decided to leave its Board of Directors at the conclusion of the Company’s 2026 Annual Meeting of Shareholders. She recently became Chief Executive Officer of SimpliSafe, which created new board service limitations.
The Company states that Ms. Schneider’s departure is solely related to her new CEO role and not due to any disagreement with Sleep Number on its operations, policies, or practices. The company publicly thanks her for her leadership and contributions and extends best wishes for her new position.
Sleep Number Corp principal accounting officer Kelly F. Baker received stock-based compensation in the form of common stock awards. On March 16, 2026, she was granted 5,581 and 2,233 shares at no cash cost, increasing her direct holdings.
On the same date, 352 shares were withheld at $3.45 per share to cover estimated taxes tied to the vesting of 966 restricted shares, which is a routine, non-market disposition. After these transactions, she directly holds 10,359 restricted stock units that are scheduled to vest over time.
Sleep Number Corp executive Melissa Barra reported routine equity compensation transactions. On 3/16/26, she received a grant of 55,804 shares of common stock, increasing her direct holdings. On the same date, 5,557 shares were withheld at $3.45 per share to cover estimated tax obligations on vesting shares, rather than sold in the market.
After these transactions, she directly holds 168,190 shares of common stock. Her reported holdings include 86,678 restricted stock units that are scheduled to vest over time, reflecting a mix of currently owned shares and time-based awards tied to continued service.
Findley Linda reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp President and CEO Linda Findley received an equity grant of 279,018 shares of Common Stock as a compensation award. The shares were granted at no cash cost to her, reflecting a non-cash stock award rather than an open‑market purchase.
After this award, she directly holds 926,624 shares of Sleep Number Common Stock. A related footnote explains that her holdings include 460,047 shares from a Restricted Stock Unit Award and 362,057 shares from a Restricted Stock Unit with Modifier Award, which vest over time, tying a substantial portion of her ownership to continued service and performance.
Sleep Number Corp executive Samuel R. Hellfeld reported routine equity compensation activity. On March 16, 2026, he received a grant of 46,038 shares of Common Stock at $0.00 per share as a share award. On the same date, 6,172 shares of Common Stock were disposed of at $3.45 per share to cover estimated tax obligations, in connection with 17,199 shares that vested from a restricted stock award, so this was not an open-market sale. After these transactions, he directly owned 115,772 Common Stock shares and indirectly held 6,505.1463 shares through a 401(k) plan. In addition, 73,193 restricted stock units will vest over time.